Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Evans

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
International Journal of Pharmaceutics|September 17, 2017
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumoursJames C Evans, Meenakshi Malhotra, Katrina Sweeney, et al.
Expert Opinion on Therapeutic Targets|March 26, 2014
The role of transcription factors in prostate cancer and potential for future RNA interference therapyKathleen A Fitzgerald, James C Evans, Joanna McCarthy, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 11, 2021
Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiolLie Yun Kok, Pauric Bannigan, Forugh Sanaee, et al.
Molecular Pharmaceutics|January 4, 2017
Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases ModelJames C Evans, Meenakshi Malhotra, Kathleen A Fitzgerald, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 9, 2016
Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivoJames C Evans, Meenakshi Malhotra, Jianfeng Guo, et al.
International Journal of Pharmaceutics|January 15, 2019
Lipids and polymers in pharmaceutical technology: Lifelong companionsJuergen Siepmann, Amina Faham, Sophie-Dorothée Clas, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
International Journal of Pharmaceutics|September 17, 2017
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumoursJames C Evans, Meenakshi Malhotra, Katrina Sweeney, et al.
Expert Opinion on Therapeutic Targets|March 26, 2014
The role of transcription factors in prostate cancer and potential for future RNA interference therapyKathleen A Fitzgerald, James C Evans, Joanna McCarthy, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 11, 2021
Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiolLie Yun Kok, Pauric Bannigan, Forugh Sanaee, et al.
Molecular Pharmaceutics|January 4, 2017
Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases ModelJames C Evans, Meenakshi Malhotra, Kathleen A Fitzgerald, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 9, 2016
Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivoJames C Evans, Meenakshi Malhotra, Jianfeng Guo, et al.
International Journal of Pharmaceutics|January 15, 2019
Lipids and polymers in pharmaceutical technology: Lifelong companionsJuergen Siepmann, Amina Faham, Sophie-Dorothée Clas, et al.
Pageof 3